COMMUNIQUÉS West-GlobeNewswire
-
VIRBAC: sur la lancée du second semestre 2023, forte croissance du chiffre d’affaires sur le premier trimestre de +10,8% à taux de change constants
16/04/2024 -
New report: For-profit clinics expanded by Ford government charging patients thousands in unlawful fees
16/04/2024 -
University of St. Augustine for Health Sciences Fills Healthcare Industry Shortages with New Innovative Programs
16/04/2024 -
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
16/04/2024 -
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
16/04/2024 -
Smart for Life to Sponsor Industry Event “What’s Up with Supps” at SupplySide East
16/04/2024 -
AssistRx Earns URAC Reaccreditation in Mail Service Pharmacy
16/04/2024 -
MEDIA ADVISORY: OWN.CANCER campaign ‘Delivering Hope’ through activation events during OWN.CANCER Week
16/04/2024 -
Better Choice Company Board of Directors Authorize Stock Repurchase Program
16/04/2024 -
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
16/04/2024 -
Kane Biotech to Host Investor Webinar
16/04/2024 -
Solera Health Expands its Curated Network to Help Payers and Employers Address High-Cost Cardiometabolic Disease
16/04/2024 -
Turnstone Biologics Appoints William Waddill to its Board of Directors
16/04/2024 -
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
16/04/2024 -
Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.
16/04/2024 -
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
16/04/2024 -
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
16/04/2024 -
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
16/04/2024 -
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
16/04/2024
Pages